FUTURE CARE CAPITAL
In pursuance of its charitable mission, Future Care Capital (FCC) will use its resources to identify and support innovation through the launch of a dedicated Innovation Fund. The Innovation Fund aims to help address major healthcare needs, such as mental health, ageing and living with chronic medical conditions, by investing in innovative enterprises. It will also have an ethical investment policy that will drive its activities in compliance with the charity’s policies and aims. The Fund will invest in UK based, early-stage, high-tech, high-growth enterprises in the field of digital health (including machine learning and AI), assisted living, services and Class I medical devices.
FUTURE CARE CAPITAL
Industry:
Biotechnology Health Care Life Science Medical Pharmaceutical
Status:
Active
Email Addresses:
[email protected]
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default LetsEncrypt Apple Mobile Web Clips Icon WordPress Content Delivery Network Font Awesome Wordpress Plugins
Similar Organizations
Aepodia
Aepodia is specialized in the strategy and delivery of early drug and Medical Devices development and provides scientific consultancy.
Aniling
Aniling brings advances in the genomics arena to everyday’s health care and disease prevention
APR Applied Pharma Research
Is a private international corporation in Switzerland and focused on the development and licenses of innovative healthcare products.
Aprea
Aprea focuses on the discovery and development of novel anticancer compounds reactivating the tumor suppressor protein p53.
Biogenes
BioGenes offers custom antibody and immunoassay development and services.
BionPharma
BionPharma develops and commercializes affordable quality generics and builds strong and effective partnerships.
Brilia
Brilia is committed to bringing intelligent and innovative lighting solutions to people everywhere so they can have a better life.
Cambio
Cambio is an excellent reputation for the supply of quality Molecular Biology reagents and consumables to scientific research laboratories.
Exprimo
Exprimo is focuses on the application of population PK, advanced PK/PD and drug-disease modelling & simulation.
FALGAGEN
Independent services (R&D, Industrial Operations, Business & Corporate Development) company expert in Hyaluronic Acid and Chitosan
ImaBiotech
ImaBiotech provides molecular imaging services and products aiming at enhancing the development of new drugs through innovative proprietary.
iQur
iQur designs vaccines to provide protection against major global health challenges
Medelinked
Medelinked is a simple way to manage your health and connect with the healthcare community around you
Okyo Pharma
Okyo Pharma focuses on novel GPCR based therapeutics for eye diseases of high unmet need and non-opioid analgesics for chronic pain.
PharmaSGP
PharmaSGP is engaged in producing and developing non-chemical and over-the-counter drugs and other healthcare products.
Spherium Biomed
Spherium professionals have extensive experience in both academic and industry environments in the process of biomedical R&D.
Biologics Consulting
Biologics Consulting is a product development consulting firm for biologics, pharmaceuticals, and medical devices.
UbiPharm
UbiPharm is committed to helping each pharmacist-customer to satisfy the demands of their clients and provide health solutions.
Xendo
Xendo is an independent consultancy and project management organization in the (bio)pharmaceutical, medical devices and healthcare fields.
Current Advisors List
Current Employees Featured
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2018-08-16 | Healthera | Future Care Capital investment in Series A - Healthera | 3 M GBP |